Mobile Site ›

What the FDA Relabeling of Abacavir Means for You and Your Patient



Subscribe

Receive notification when new Hot Topics are published:

HLA-B*5701 Genotyping5

Slide 20

November 2008

At Mayo Medical Laboratories, the HLA-B*5701 allele typing is done by a genotyping method as described by Dr. O’Kane under the unit code 89346 with the published name HLA-B*5701 Genotype, Abacavir Hypersensitivity.

This assay is useful for predicting the likelihood of hypersensitivity reactions to abacavir in HIV-infected patients, based on the presence of the HLA-B*5701 allele and it is therefore useful to exclude these patients if they’re positive for this allele.

HLA-B*5701 Genotyping5

 


Jump to section:


Key